DRREDDY5 months ago
Dr. Reddy’s Laboratories Limited (drreddy) Launches First-to-market Bosutinib Tablets 400mg in the U.S.
Dr. Reddy's Laboratories Limited (DRREDDY) announces the first-to-market launch of Bosutinib Tablets 400mg in the U.S., expanding its oncology portfolio.
